Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

420
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
420
Renal Corpuscle01:20

Renal Corpuscle

1.8K
The glomerulus and Bowman's capsule are two essential components of the nephron, which is the functional unit of the kidney. These microscopic structures play a critical role in the process of blood filtration to produce urine.
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
1.8K
Glaucoma: Overview01:25

Glaucoma: Overview

532
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
532

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Incorporating frailty and disease severity into treatment decisions for older patients with ANCA-associated vasculitis.

Rheumatology (Oxford, England)·2026
Same author

A Pathway to High Quality Clinical Trials in IgA Vasculitis Nephritis: Meeting Proceedings From a Multiprofessional International Collaborative Workshop.

Kidney international reports·2026
Same author

Albuminuria after induction treatment and kidney prognosis in ANCA-associated glomerulonephritis.

Clinical kidney journal·2025
Same author

ALIGNing the treatment of IgA nephropathy: Reducing proteinuria with endothelin A receptor inhibition.

Med (New York, N.Y.)·2025
Same author

A randomised, two-arm (1:1 ratio), double blind, placebo controlled phase III trial to assess the efficacy, safety, cost and cost-effectiveness of Rituximab in treating de novo or relapsing NS in patients with MCD/FSGS (TURING).

BMC nephrology·2024
Same author

Prospective study of the effect of rituximab on kidney function in membranous nephropathy.

Clinical kidney journal·2024
Same journal

Beyond the High: A Narrative Review of the Chronic Complications of Recreational Ketamine Use.

British journal of hospital medicine (London, England : 2005)·2026
Same journal

Prolonged Undiagnosed Prodromal Symptoms.

British journal of hospital medicine (London, England : 2005)·2026
Same journal

Human Factors and Deterioration: What Success Factors Facilitate Escalation of Care and How Can These Be Applied More Reliably?

British journal of hospital medicine (London, England : 2005)·2026
Same journal

Comparative Evaluation of Functional Outcomes and Postoperative Complications After Minimally Invasive Fixation for Acromioclavicular Joint Injuries.

British journal of hospital medicine (London, England : 2005)·2026
Same journal

A Systematic Review of Functional MRI Studies on Seasonal Modulation of Brain Functional Connectivity.

British journal of hospital medicine (London, England : 2005)·2026
Same journal

More Than Myocarditis? Cardiac Involvement in Phaeochromocytoma-A Case Report.

British journal of hospital medicine (London, England : 2005)·2026
查看所有相关文章

相关实验视频

Updated: Jun 18, 2025

Isolation of Glomeruli and In Vivo Labeling of Glomerular Cell Surface Proteins
09:12

Isolation of Glomeruli and In Vivo Labeling of Glomerular Cell Surface Proteins

Published on: January 18, 2019

9.1K

在原发性淋巴结膜炎中取得了进展.

Betsy Ellison1, Ruzaika Cader1, Lisa Willcocks1

  • 1Department of Nephrology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.

British journal of hospital medicine (London, England : 2005)
|July 30, 2024
PubMed
概括
此摘要是机器生成的。

主要的血球炎,包括IgA脏病 (IgAN) 和FSGS,导致脏疾病. 新的治疗方法和KDIGO指导方针为减少进展到末期病提供了希望.

关键词:
焦点细分型淋巴结核硬化在IgA脏病发作中,IgA脏病发作膜性质膜炎 (glomerulonephritis) 是一种表膜性质膜炎.疾病变化最小的变化

更多相关视频

Using 2-Photon Microscopy to Quantify the Effects of Chronic Unilateral Ureteral Obstruction on Glomerular Processes
11:47

Using 2-Photon Microscopy to Quantify the Effects of Chronic Unilateral Ureteral Obstruction on Glomerular Processes

Published on: March 4, 2022

2.2K
An Efficient Sieving Method to Isolate Intact Glomeruli from Adult Rat Kidney
10:14

An Efficient Sieving Method to Isolate Intact Glomeruli from Adult Rat Kidney

Published on: November 1, 2018

13.6K

相关实验视频

Last Updated: Jun 18, 2025

Isolation of Glomeruli and In Vivo Labeling of Glomerular Cell Surface Proteins
09:12

Isolation of Glomeruli and In Vivo Labeling of Glomerular Cell Surface Proteins

Published on: January 18, 2019

9.1K
Using 2-Photon Microscopy to Quantify the Effects of Chronic Unilateral Ureteral Obstruction on Glomerular Processes
11:47

Using 2-Photon Microscopy to Quantify the Effects of Chronic Unilateral Ureteral Obstruction on Glomerular Processes

Published on: March 4, 2022

2.2K
An Efficient Sieving Method to Isolate Intact Glomeruli from Adult Rat Kidney
10:14

An Efficient Sieving Method to Isolate Intact Glomeruli from Adult Rat Kidney

Published on: November 1, 2018

13.6K

科学领域:

  • 腎臟病學 (nephrology) 是一種醫學.
  • 免疫学 免疫学 免疫学

背景情况:

  • 初级淋巴结核炎包括IgA脏病 (IgAN),初级膜性脏病 (PMN),焦点细分淋巴结核病 (FSGS) 和最小变化疾病 (MCD).
  • 这些罕见的脏疾病导致严重的医疗保健费用,因为末期脏疾病 (ESKD) 需要透析或移植.
  • 从历史上看,原发性淋巴结膜炎的发病原因尚不清楚,这影响了治疗策略.

研究的目的:

  • 审查目前用于治疗Igan,PMN,FSGS和MCD的病改善全球结果 (KDIGO) 指南.
  • 讨论最近在了解这些凝聚氨基酸的病变发生方面取得的进展.
  • 突出新型治疗剂和正在进行的临床试验,影响患者护理.

主要方法:

  • 对国际KDIGO指南的文献综述.
  • 综合了关于原发性淋巴结膜炎病变的最新研究.
  • 对新型治疗方法的已完成和正在进行的临床试验数据的分析.

主要成果:

  • 了解疾病演变的最新进展导致了新的治疗药物.
  • 临床试验显示,有很大的潜力改变对原发性凝聚氨基酸的护理标准.
  • 这些发展预计将减少进展到ESKD的患者数量.

结论:

  • 新的治疗策略和最新的KDIGO指南正在改变原发性淋巴结膜炎的管理.
  • 对病变发生的更好理解正在推动开发更有效的治疗方法.
  • 患有Igan,PMN,FSGS和MCD的患者的前景正在改善,ESKD发病率可能下降.